tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Exelixis upgraded to Outperform from Market Perform at Leerink
PremiumThe FlyExelixis upgraded to Outperform from Market Perform at Leerink
2d ago
Exelixis’s Zanzalintinib Shows Promise in Phase III Trial, Justifying Buy Rating Despite Safety Concerns
Premium
Ratings
Exelixis’s Zanzalintinib Shows Promise in Phase III Trial, Justifying Buy Rating Despite Safety Concerns
3d ago
Midday Fly By: AWS hit by outage, Kering sells beauty unit
Premium
The Fly
Midday Fly By: AWS hit by outage, Kering sells beauty unit
3d ago
Exelixis reports detailed results from STELLAR-303
PremiumThe FlyExelixis reports detailed results from STELLAR-303
3d ago
Exelixis announces results from analysis of CABINET Phase 3 trial of CABOMETYX
Premium
The Fly
Exelixis announces results from analysis of CABINET Phase 3 trial of CABOMETYX
4d ago
Exelixis: Buy Rating Backed by Strategic Positioning and Growth Prospects
Premium
Ratings
Exelixis: Buy Rating Backed by Strategic Positioning and Growth Prospects
8d ago
Exelixis: Strong Growth Potential with Promising Zanzalintinib Outlook and Attractive Investment Opportunity
PremiumRatingsExelixis: Strong Growth Potential with Promising Zanzalintinib Outlook and Attractive Investment Opportunity
1M ago
Exelixis price target raised to $50 from $46 at Morgan Stanley
Premium
The Fly
Exelixis price target raised to $50 from $46 at Morgan Stanley
1M ago
Exelixis initiated with a Buy at Goldman Sachs
Premium
The Fly
Exelixis initiated with a Buy at Goldman Sachs
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100